A study published in the Dec. 1 issues of the journal SLEEP, reports growing evidence that short sleep duration is contributing to the "diabetes epidemic."
Dr. Anstella Robinson, Stanford, Calif., called on respiratory therapists to be more vigilant in caring for children with sleep disorders in the Dec. 2 session on Exploring Pediatric Sleep Disorders at the American Association for Respiratory Care (AARC) meeting in Orlando.
CHAD Therapeutics has agreed to sell to all of its assets related to the oxygen conserver business to Inovo, a privately held manufacturer in Naples, Fla.
The Centers for Medicare & Medicaid Services (CMS) will announced the accreditation deadline for all providers at a special open door forum 2-3:30 p.m. EST Wednesday, Dec. 19.
The Centers for Medicare & Medicaid Services (CMS) is expected to issue its decision memo regarding home sleep testing some time after 4 p.m. EST today . The decision comes ahead of the final rule in March 2008. A 90-day comment period will follow the decision memo.
On Nov. 27, Respironics celebrated the opening of a new U.S. headquarters for its Respiratory Drug Delivery (RDD) business at an opening reception. John Miclot, president and CEO, joined associates and invited guests, which included Mayor Michael M. Luther of Parsippany.
Chronic obstructive pulmonary disease (COPD) is on the rise in women in prevalence, morbidity and mortality. By 2000, the number of women dying from COPD surpassed the number of men. But the rising number of cases in women has not been matched by medical understanding of the disease’s apparent gender-bias.
In the January/February 2008 issue, Respiratory Management will feature a celebration of the most influential products in recent history. To support the product selections, RM has asked respiratory providers and clinicians to chime in with their thoughts on what products should make the cut in oxygen, sleep and asthma categories.
On Nov. 8, members of the House and Senate participated in a Congressional briefing, hosted by the COPD Congressional Caucus in a strong showing of support for two pulmonary rehabilitation bills — S. 329 and H.R. 552. The bills, if passed, would add a pulmonary rehab benefit to Medicare.
Yesterday, Invacare announced revised trade show plans for 2008 that excluded participation in the two Medtrade shows. A formal statement from the company said it would shift resources "from a key focus on one or two trade shows to a broader focus on specialized trade shows and more customer-oriented training activities."
The American College of Asthma, Allergy & Immunology (ACAAI) annual meeting kicked off Nov. 8 in Grapevine, Texas, at the Gaylord Texan Resort & Convention Center. More than 1,600 physicians and other health care professionals attended the show.
U.S. patients suffering from respiratory disease could be greatly helped if a bill introduced in late October by Congressman Mike Ross (D-Ark.) is passed, according to Toni Rodriguez, president of the American Association for Respiratory Care (AARC).
Last week, the National Sleep Foundation kicked off its first Drowsy Driving Week (Nov. 5-11) to raise awareness of the dangers of drowsy driving and advocate for preventative measures at the state level. Respironics joined the program as lead sponsor.
At the American College of CHEST Physicians annual meeting, a new study presented by Dr. Donald Tashkin, with the David Geffen School of Medicine at UCLA, revealed that COPD patients treated with Foradil Aerolizer (formoterol fumarate inhalation powder), a long-acting inhaled bronchodilator, and tiotropium experienced statistically significant greater improvement in lung function than patients treated with tiotropium alone.
